stars 1 stars 2 stars 3

Bespak is a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery devices and drug-device combination products. Bespak develops and manufactures finished pharmaceutical products, as well as being a leading global supplier of drug delivery devices and componentry to the pharmaceutical industry. With a long history in the development and commercial supply of pressurised Metered Dose Inhalers (pMDIs), Bespak supplies a major proportion of the world’s pMDI dosing valves and actuators, and also specialises in the industrialisation and high-volume manufacture of complex dry powder inhaler (DPI) devices. Headquartered in Holmes Chapel, UK, the company’s service offering spans early-stage feasibility, analytical and product development, through pilot-scale, clinical and commercial-scale drug product fill-finish, to device and component manufacturing.

Bespak Questions

The Bespak annual revenue was $37.6 million in 2026.

Chris Hirst is the CEO of Bespak.

399 people are employed at Bespak.

Bespak is based in Holmes Chapel, England.

The NAICS codes for Bespak are [339, 334, 33].

The SIC codes for Bespak are [384, 382, 38].

Top Bespak Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users